Diana-Alexandra Ertl

8PUBLICATIONS
15CO-AUTHORS
Photonics, optoelectronics and optical communicationsInfant and child healthPaediatrics not elsewhere classifiedBehavioural epidemiologyObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 23, 2026
Hyperparathyroidism after 3 years of burosumab in children affected with X-linked hypophosphatemia.

|May 20, 2026
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

|Oct 01, 2025
Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry.

Agnès Linglart, Cyril Amouroux, Iva Gueorguieva

|Sep 30, 2025
Burosumab prevents further height deficit in toddlers affected by XLH.

Elisa Sala, Jugurtha Berkenou, Anya Rothenbuhler

|Oct 13, 2023
Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.

Emese Boros, Diana-Alexandra Ertl, Jugurtha Berkenou

|Jul 13, 2023
Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.

Diana-Alexandra Ertl, Guiomar Perez de Nanclares, Harald Jüppner

Pageof 2

Frequent Collaborators

6 joint publications

Agnès Linglart

3 joint publications

Anya Rothenbuhler

2 joint publications

Iva Gueorguieva

2 joint publications

Justine Bacchetta